Trial Profile
Safety and Efficacy Study on Deoxyspergualin (NKT-01) in Patients With Uncontrolled Lupus Nephritis Receiving Oral Corticosteroids and Prior Treatment of Standard Immunosuppressive Therapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Gusperimus (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Nippon Kayaku
- 01 Apr 2014 New trial record